Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olga Derman

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Lancet (London, England)|September 6, 2011
Early assessment of cancer outcomes in New York City firefighters after the 9/11 attacks: an observational cohort studyRachel Zeig-Owens, Mayris P Webber, Charles B Hall, et al.
Cancer|November 27, 2019
Epidemiology and survival trend of adult T-cell leukemia/lymphoma in the United StatesUrvi A Shah, Nishi Shah, Baozhen Qiao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2019
Barriers to Allogeneic Hematopoietic Stem Cell Transplantation for Human T Cell Lymphotropic Virus 1-Associated Adult T Cell Lymphoma-Leukemia in the United States: Experience from a Large Cohort in a Major Tertiary CenterDiego Adrianzen Herrera, Noah Kornblum, Ana Acuna-Villaorduna, et al.
Blood Advances|January 4, 2018
Hispanic ethnicity is associated with younger age at presentation but worse survival in acute myeloid leukemiaKarine Darbinyan, Aditi Shastri, Anjali Budhathoki, et al.
Leukemia & Lymphoma|June 18, 2019
High prevalence of pulmonary findings in computed tomographies of HTLV-1-infected patients with and without adult-T cell leukemia/lymphoma - implications for stagingAna Acuna-Villaorduna, Jesus Gonzalez-Lugo, B Hilda Ye, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 19, 2020
Multiple Myeloma in Hispanics: Incidence, Characteristics, Survival, Results of Discovery, and Validation Using Real-World and Connect MM Registry DataGurbakhash Kaur, Mateo Mejia Saldarriaga, Nishi Shah, et al.
Journal of Hematology & Oncology|January 5, 2020
Axicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma including two with HIV and viral hepatitisAhmed Abbasi, Stephen Peeke, Nishi Shah, et al.
Blood|August 15, 2018
North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapiesUrvi A Shah, Elaine Y Chung, Orsi Giricz, et al.
Clinical Hematology International|March 15, 2023
Outcome of Stem Cell Transplantation in HTLV-1-Associated North American Adult T-Cell Leukemia/LymphomaAbdul-Hamid Bazarbachi, Daniel Reef, Hiba Narvel, et al.
Stem Cell Investigation|October 11, 2021
Patterns of leukocyte recovery predict infectious complications after CD19 CAR-T cell therapy in a real-world settingAstha Thakkar, Zhu Cui, Stephen Zachary Peeke, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Lancet (London, England)|September 6, 2011
Early assessment of cancer outcomes in New York City firefighters after the 9/11 attacks: an observational cohort studyRachel Zeig-Owens, Mayris P Webber, Charles B Hall, et al.
Cancer|November 27, 2019
Epidemiology and survival trend of adult T-cell leukemia/lymphoma in the United StatesUrvi A Shah, Nishi Shah, Baozhen Qiao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2019
Barriers to Allogeneic Hematopoietic Stem Cell Transplantation for Human T Cell Lymphotropic Virus 1-Associated Adult T Cell Lymphoma-Leukemia in the United States: Experience from a Large Cohort in a Major Tertiary CenterDiego Adrianzen Herrera, Noah Kornblum, Ana Acuna-Villaorduna, et al.
Blood Advances|January 4, 2018
Hispanic ethnicity is associated with younger age at presentation but worse survival in acute myeloid leukemiaKarine Darbinyan, Aditi Shastri, Anjali Budhathoki, et al.
Leukemia & Lymphoma|June 18, 2019
High prevalence of pulmonary findings in computed tomographies of HTLV-1-infected patients with and without adult-T cell leukemia/lymphoma - implications for stagingAna Acuna-Villaorduna, Jesus Gonzalez-Lugo, B Hilda Ye, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 19, 2020
Multiple Myeloma in Hispanics: Incidence, Characteristics, Survival, Results of Discovery, and Validation Using Real-World and Connect MM Registry DataGurbakhash Kaur, Mateo Mejia Saldarriaga, Nishi Shah, et al.
Journal of Hematology & Oncology|January 5, 2020
Axicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma including two with HIV and viral hepatitisAhmed Abbasi, Stephen Peeke, Nishi Shah, et al.
Blood|August 15, 2018
North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapiesUrvi A Shah, Elaine Y Chung, Orsi Giricz, et al.
Clinical Hematology International|March 15, 2023
Outcome of Stem Cell Transplantation in HTLV-1-Associated North American Adult T-Cell Leukemia/LymphomaAbdul-Hamid Bazarbachi, Daniel Reef, Hiba Narvel, et al.
Stem Cell Investigation|October 11, 2021
Patterns of leukocyte recovery predict infectious complications after CD19 CAR-T cell therapy in a real-world settingAstha Thakkar, Zhu Cui, Stephen Zachary Peeke, et al.
Pageof 2